Clinical Trials Directory

Trials / Conditions / Infectious Diseases

Infectious Diseases

50 registered clinical trials studyying Infectious Diseases10 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingA Study to Learn About the Study Medicine - Zavicefta in Patients With Sepsis or Loss of Kidney Function in Ja
NCT06864585
Pfizer
RecruitingPrescription Support System for Antimicrobial Use in Belgian Primary Care
NCT07347015
KU LeuvenN/A
RecruitingFostering Prosocial Preventive Behaviours Through Awe
NCT07406529
The University of Hong KongN/A
RecruitingA Phase 1 Study of the Safety and Tolerability of Single and Multiple Ascending Doses of BWC0977 in Healthy Vo
NCT07029932
Bugworks Research Inc.Phase 1
Not Yet RecruitingOmaha System-Based Health Application on Improving Knowledge, Attitude, and Behaviors Regarding Infectious Dis
NCT07048301
Kocaeli UniversityN/A
Active Not RecruitingRapamycin and Infection-related Illness
NCT07054320
Hoskinson Health and Wellness Clinic
RecruitingImpaired Type I IFN Immunity Due to Autoantibodies or a Genetic Defect: a Prospective National Cohort
NCT06762002
Institut National de la Santé Et de la Recherche Médicale, France
Not Yet RecruitingBiobank of Samples From Patients With Infectious Diseases
NCT06722131
Assistance Publique - Hôpitaux de Paris
Active Not RecruitingA Phase 2 Study to Evaluate JCXH-105, an srRNA-based Herpes Zoster Vaccine
NCT06581575
Immorna Biotherapeutics, Inc.Phase 2
Enrolling By InvitationReal-world Multicentre Study of AZtreonam-AVIbactam Treatment With Infections or Suspected Infections Caused b
NCT07176247
French Society for Intensive Care
TerminatedThe Safety, Tolerability, and Pharmacokinetics of Single and Multiple Ascending Doses of BWC0977 in Healthy Ad
NCT05942820
Bugworks Research Inc.Phase 1
Active Not RecruitingKey Technology Research and Application Demonstration of Individual Protective Equipment for High-Level Biosaf
NCT06697379
Minghui Li
UnknownEvaluate Bioequivalence of Burotam (1/1 g/Vial)
NCT05654090
Yung Shin Pharm. Ind. Co., Ltd.Phase 4
CompletedEvaluating Patient Comfort and Environmental Conditions in the Carecube Negative Pressure Isolation Chamber.1
NCT05468723
Carecubes, Inc.
CompletedA First in Human Study of the Safety and Tolerability of Single and Multiple Doses of BWC0977 in Healthy Volun
NCT05088421
Bugworks Research Inc.Phase 1
CompletedResearch on the Application and Mechanism of New Biological Probes in Biomedicine
NCT04977739
Nanfang Hospital, Southern Medical University
Not Yet RecruitingLMP1 CAR-T for Patients With LMP1 Positive Infectious Diseases and Hematological Malignancies
NCT04657965
Zhejiang UniversityEARLY_Phase 1
UnknownA Study on the Prospective Cohort Library of COVID-19 in Southeran
NCT04342702
Second Affiliated Hospital of Wenzhou Medical University
CompletedIncidence of Allergic Manifestations and Infectious Episodes in Healthy Term Infants at Risk for Dysbiosis
NCT04182425
Bledina
CompletedGroup B Strep Correlates of Protection Study
NCT06431217
University of Witwatersrand, South Africa
CompletedSafety of Discontinuing Patient Antibiotic Treatment
NCT02900820
Spanish Society of Family and Community MedicineN/A
CompletedThe Added Value of a Mobile Application of Community Case Management on Pediatric Referral Rates in Malawi
NCT02763345
University of WashingtonN/A
CompletedBaby Vaccine Study (Sched3)
NCT02482636
University of OxfordPhase 2
CompletedA Pilot Study Comparing the Immunogenicity of Fendrix vs. Double-dose Engerix B in HIV-infected Non-responders
NCT02434848
Sheffield Teaching Hospitals NHS Foundation TrustPhase 2 / Phase 3
CompletedSpecificity Study of Diagnostic for Chagas Disease
NCT02544139
InBios International, Inc.
Active Not RecruitingLoewenKIDS - Infections and the Development of the Immune System
NCT02654210
Helmholtz Centre for Infection Research
UnknownSafety and Efficacy Study of High Dose Colistin
NCT02162966
King Saud Medical CityPhase 4
CompletedA Study of Rivaroxaban (JNJ-39039039) on the Venous Thromboembolic Risk in Post-Hospital Discharge Patients
NCT02111564
Janssen Research & Development, LLCPhase 3
CompletedPrevention of Necrotizing Enterocolitis of Premature Newborns Under Less Than 1500 g Using Probiotics
NCT02245815
Coordinación de Investigación en Salud, MexicoN/A
CompletedSensitivity Study of Diagnostic for Detection of Chagas Infection
NCT02134548
InBios International, Inc.
CompletedResidual Effect of Chlorhexidine-alcohol Compared to Triclosan-alcohol
NCT01762904
Universidad de GuanajuatoPhase 3
CompletedSpecificity Study of Diagnostic for Early Detection of Dengue Infection
NCT02107677
InBios International, Inc.
UnknownHospital Microbial Ecology Follow the Introduction of Ertapenem and Other Newly Introduced Antibiotic Over Tim
NCT01611025
Taipei Veterans General Hospital, Taiwan
CompletedIsopropyl Alcohol Against Chlorhexidine - Isopropyl Alcohol as Antiseptics to Prevent Hemoculture's Contaminat
NCT01361997
Universidad de GuanajuatoPhase 3
CompletedChlorhexidine Against Sodium Hypochlorite as Skin Antiseptics
NCT01321125
Universidad de GuanajuatoPhase 3
CompletedSensitivity Study of Diagnostic for Early Detection of Dengue Infection
NCT02059122
InBios International, Inc.
CompletedSevere Necrotizing Enterocolitis in Preterm Newborns <1500g Using Probiotics
NCT02226263
Coordinación de Investigación en Salud, MexicoPhase 2
CompletedReducing Inappropriate Antibiotic Prescribing by Primary Care Clinicians
NCT01099943
University of Colorado, DenverN/A
CompletedA Study to Assess Efficacy and Safety of IV/PO Moxifloxacin in the Treatment of cSSSIs
NCT00828971
BayerPhase 3
CompletedStudy to Investigate the Causes of Fever in Children Living in Urban Dar es Salaam and Rural Ifakara
NCT01812785
Swiss Tropical & Public Health Institute
CompletedDrug Utilization Prevalence in a Pediatric Care Medical Center
NCT00550706
Rambam Health Care Campus
CompletedEffect of the Consumption of a Fermented Milk on Common Infections in Shift-workers
NCT01033799
Danone Global Research & Innovation CenterN/A
TerminatedDevelopment of Immune Globulin Treatment for Avian Flu
NCT00383071
National Institute of Allergy and Infectious Diseases (NIAID)Phase 2
CompletedHybrid Imaging Modalities for the Evaluation of Infection
NCT00230152
Rambam Health Care CampusN/A
CompletedPhase I Trial for Pharmacokinetic Characteristics of Factive 200mg Intravenous Formulation (Gemifloxacin 200mg
NCT01879007
LG Life SciencesPhase 1
CompletedEfficacy Trial to Examine Efficacy of Multimicronutrient Home Supplementation in Infants
NCT00276198
Soroka University Medical CenterPhase 3
CompletedBifidobacterium Lactis BB12 and Xylitol Delivered With a Novel Slow-release Pacifier
NCT00638677
University of TurkuPhase 4
TerminatedTreatment of Rubeosis Iridis With Open-Label Anecortave Acetate Sterile Suspension ( 15 mg.).
NCT00211471
Manhattan Eye, Ear & Throat HospitalPhase 2
CompletedBAY 0 9867 Cipro Pediatric Use Study (QUIP)
NCT00761462
BayerPhase 3
RecruitingStudies of the Pathogenesis of HIV Infection in Human Peripheral Blood Cells and/or Body Fluids in People Livi
NCT00001281
National Institute of Allergy and Infectious Diseases (NIAID)